Hims & Hers vs Eden
$238/mo against $298/mo for tirzepatide. Which is worth it, and for whom.
Updated 2026-09-18
How we are paid: one company on this page — Coreage Rx — pays us a commission if you sign up through our link. It does not buy a better score, a higher position, or the removal of a single criticism. Our rating method and full disclosure are both public.
Both sell tirzepatide. Hims & Hers costs $238 a month and Eden costs $298, a difference of $60 a month or about $720 a year. The other differences matter more than the money if this is your first course.
Hims & Hers is widest range of formats. Eden is low advertised medication price. They are not aimed at the same person, and the cheaper one is not automatically the right answer — particularly if this is your first course and you expect a slow titration.
What this means for your titration. Eden holds one price at every dose and Hims & Hers does not — so this gap widens as you titrate toward a therapeutic dose, exactly when you can least afford a surprise.
Side by side
| Hims & Hers | Eden | |
|---|---|---|
| Advertised from | $199 | $199 |
| Membership on top | $39/mo | $99/mo |
| True monthly cost | $238 | $298 |
| Roughly, per year | $2,856 | $3,576 |
| Price includes medication | Yes | Yes |
| Names its pharmacy | Not published | Not published |
| Our score | 3.5 / 5 | 3.1 / 5 |
Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.
The differences that affect treatment
They differ on 3 of the 7 things we track, and behave the same on the other 4. The differences are what the price gap is actually buying.
| Hims & Hers | Eden | |
|---|---|---|
| Price is the same at every dose | No | Yes |
| Offers an oral or sublingual option | Yes | No |
| Can dispense FDA-approved branded medication | Yes | No |
What each programme publishes: Hims & Hers
- Weight-loss membership advertised at $39 for the first month.
- Compounded GLP-1 injections priced from $199/month.
- Oral medication kits priced from $79/month.
- Branded Zepbound offered at $1,899/month.
- Company has announced oral semaglutide pricing starting around $49/month, with the 1.5 mg dose around $149/month.
Where it wins: One account covers oral, compounded injectable and branded options. Watch for: The advertised entry prices and the membership are separate charges. Add $39/month to whatever medication figure you were quoted.
What each programme publishes: Eden
- Compounded semaglutide advertised at $99/month.
- Compounded tirzepatide advertised at $199/month.
- Membership is $39 as an introductory rate, then $99/month ongoing.
- True ongoing cost for tirzepatide lands near $298/month once membership is included.
Where it wins: Genuinely low medication-only pricing. Watch for: The $99 semaglutide headline becomes roughly $198/month once the membership renews at its ongoing rate.
Strengths of each
Hims & Hers.
- One account covers oral, compounded injectable and branded options.
- Large enough to keep supply steady when smaller sellers run dry.
- Branded Zepbound is available without leaving the platform.
Eden.
- Genuinely low medication-only pricing.
- Fast onboarding with flat rates across published dose ranges.
How they score
| What we weigh | Weight | Hims & Hers | Eden |
|---|---|---|---|
| True monthly cost | 30% | 3.4 | 3.1 |
| Price honesty | 20% | 3.2 | 2.6 |
| Clinical support | 20% | 3.6 | 3.3 |
| Pharmacy sourcing | 15% | 3.9 | 3.4 |
| Cancelling | 15% | 3.3 | 3.1 |
Hims & Hers scores higher overall at 3.5 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.
Which suits you
- Pick Hims & Hers if cost is the binding constraint. Over a year the gap is about $720, which is real money for the same class of medication.
- Pick Eden if what it does better matters to you — genuinely low medication-only pricing.
- Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.
The verdict
For most people starting out, Hims & Hers at $238 a month is the more defensible choice on arithmetic alone. Eden earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Hims & Hers and Eden.
How they sit against everyone else
| Programme | Per month | Dose-price | Our score |
|---|---|---|---|
| Coreage Rx Best overall on true monthly cost | $199 | Flat | 4.5 |
| Trimi Lowest flat price with named pharmacies | $125 | Varies | 4.6 |
| PlexusDx Pharmacy transparency and genetic testing | $189 | Varies | 4.4 |
| Ozari Health Lowest advertised semaglutide price | $125 | Varies | 4.4 |
| Fifty 410 Prepaid blocks with no subscription | $133 | Varies | 4.2 |
| Ivím Health Unlimited clinician access | $199 | Varies | 4 |
| Mochi Health Insurance concierge support | $278 incl. $79 fee | Varies | 3.6 |
| Coby Health Multi-month value with supplies included | $239 | Varies | 3.6 |
| Hims & Hers Widest range of formats | $238 incl. $39 fee | Varies | 3.5 |
| Ro Branded medication with insurance help | $448 incl. $149 fee | Varies | 3.5 |
| Zealthy Low-cost entry with insurance routing | $216 | Varies | 3.5 |
| LifeMD Insurance coordination | $149 | Varies | 3.5 |
Read next
- Hims & Hers tirzepatide review
Widest range of formats. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $238 a month.
- Eden tirzepatide review
Low advertised medication price. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $298 a month.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- The twelve-month cost
Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.
- Best programmes if this is your first time
Ranked on how they price the dose ladder and how reachable support is — the two things that decide whether a beginner stays on treatment.